These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33409012)
1. Clinicopathological Spectrum of Primary and Metastatic Neuroendocrine Neoplasms. Hashmi AA; Ali J; Khan K; Ahmed O; Rehman AU; Irfan M; Haroon S; Asif MG Cureus; 2020 Nov; 12(11):e11764. PubMed ID: 33409012 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors. Hashmi AA; Ali J; Yaqeen SR; Ahmed O; Asghar IA; Irfan M; Asif MG; Edhi MM; Hashmi S Cureus; 2021 Jan; 13(1):e12640. PubMed ID: 33585126 [TBL] [Abstract][Full Text] [Related]
3. Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective Review. Le BK; McGarrah P; Paciorek A; Mohamed A; Apolo AB; Chan DL; Reidy-Lagunes D; Hauser H; Rivero JD; Whitman J; Batty K; Zhang L; Raj N; Le T; Bergsland E; Halfdanarson TR Clin Genitourin Cancer; 2023 Jun; 21(3):403-414.e5. PubMed ID: 37031047 [TBL] [Abstract][Full Text] [Related]
4. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Bellizzi AM Adv Anat Pathol; 2013 Sep; 20(5):285-314. PubMed ID: 23939147 [TBL] [Abstract][Full Text] [Related]
5. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. Hoskoppal D; Epstein JI; Gown AM; Arnold Egloff SA; Gordetsky JB; Shi CJ; Giannico GA Histopathology; 2020 Mar; 76(4):550-559. PubMed ID: 31595536 [TBL] [Abstract][Full Text] [Related]
6. [Neuroendocrine neoplasms of the head and neck]. Konukiewitz B; Agaimy A; Weichert W; Klöppel G Pathologe; 2018 Feb; 39(1):27-34. PubMed ID: 29313083 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
8. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy? Koo J; Dhall D Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790 [TBL] [Abstract][Full Text] [Related]
9. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives? Scoazec JY Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs. Park HK; Kwon GY J Korean Med Sci; 2023 Mar; 38(11):e85. PubMed ID: 36942393 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index > 20. Kasajima A; Konukiewitz B; Oka N; Suzuki H; Sakurada A; Okada Y; Kameya T; Ishikawa Y; Sasano H; Weichert W; Klöppel G Neuroendocrinology; 2019; 108(2):109-120. PubMed ID: 30485860 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system]. Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440 [TBL] [Abstract][Full Text] [Related]
14. Gastroenteropancreatic neuroendocrine tumours: Clinicopathological evaluation at Shifa International Hospital, Islamabad. Mamoon N; Naveed H; Abid M; Nasir H; Ahmad IN; Hameed Z; Khan AH J Pak Med Assoc; 2021 Feb; 71(2(A)):492-496. PubMed ID: 33819235 [TBL] [Abstract][Full Text] [Related]
15. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors. Barbareschi M; Roldo C; Zamboni G; Capelli P; Cavazza A; Macri E; Cangi MG; Chilosi M; Doglioni C Am J Surg Pathol; 2004 Sep; 28(9):1169-76. PubMed ID: 15316316 [TBL] [Abstract][Full Text] [Related]
16. PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. Long KB; Srivastava A; Hirsch MS; Hornick JL Am J Surg Pathol; 2010 May; 34(5):723-9. PubMed ID: 20414099 [TBL] [Abstract][Full Text] [Related]
20. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary. Abdel-Rahman O Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]